A Case of Varicelliform Zoster in a Patient Treated with Etanercept for Ankylosing Spondylitis
Journal of Rheumatic Diseases
;
: 186-189, 2015.
Article
in English
| WPRIM
| ID: wpr-36843
ABSTRACT
Tumor necrosis factor-alpha (TNF-alpha) inhibitors are increasingly used in treatment of inflammatory disorders because of their immunomodulatory efficacy. Increased risk of infection is an adverse effect of anti-TNF-alpha therapy. The incidence rate and severity of herpes zoster is significantly higher in patients on anti-TNF-alpha therapy than in the general population. The clinical presentation of varicella zoster virus infection is also often atypical in these patients. We experienced a patient who presented with a disseminated varicelliform rash while on etanercept therapy for ankylosing spondylitis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Spondylitis, Ankylosing
/
Incidence
/
Tumor Necrosis Factor-alpha
/
Herpesvirus 3, Human
/
Exanthema
/
Etanercept
/
Herpes Zoster
Type of study:
Incidence study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Journal of Rheumatic Diseases
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS